Obstetrics, Gynecology and Reproduction

Advanced search

A case of mesenteric vein thrombosis developed in the first trimester of pregnancy after in vitro fertilization and embryo transfer in a patient with antiphospholipid syndrome

Full Text:


Combined thrombophilia is known as a probable cause of recurrent in vitro fertilization (IVF) failures. The present clinical case demonstrates the importance of considering the possibility of inherited or acquired thrombophilia in patients under the preparation for IVF. Thromboses of rare locations (hepatic vein, splenic vein, mesenteric vein, ovarian vein, retinal vein, cerebral vein, portal vein, axillary and subclavian vein) are life-threatening conditions. Most often thrombosis of atypical location develops in patients with inherited hemostatic defects, e.g. genetic thrombophilia. Such thromboses can also result from acquired abnormalities of hemostasis, which include antiphospholipid syndrome, pregnancy-associated hypercoagulability, IVF, oral contraception, or ovarian hyper-stimulation within IVF procedures.

About the Authors

N. S. Stuleva
I.M. Sechenov First Moscow State Medical University
Russian Federation

PhD, Associate Professor, Department of Obstetrics and Gynecology № 2,

62 St. Zemlyanoi Val, Moscow 109004, Russia


A. V. Vorobiev
I.M. Sechenov First Moscow State Medical University
Russian Federation

PhD, Associate Professor, Department of Obstetrics and Gynecology № 2

62 St. Zemlyanoi Val, Moscow 109004, Russia

E. A. Orudzhova
City Clinical Hospital № 67 named after L.A. Vorokhobov
Russian Federation

PhD, Obstetrician-gynecologist, Head of Center for Ambulatory Medical Care

Russia, 123423 Moscow, Salam Adilya St., 2/44


1. Martinelli I., De Stefano V. Rare thrombosis of cerebral, splanchnic and upper-extremity veins: а narrative review. Thromb Haemost. 2010;103(6):1136–44.

2. Liatsikos S.A., Tsikouras Р., Manav B. et al. Inherited thrombophilia and reproductive disorders. J Turk Ger Gynecol Assoc. 2016;12(17):45–50.

3. High-risk pregnancy. [Beremennost' vysokogo riska. Pod red. A.D. Makacariya, F.A. Chervenaka, V.O. Bicadze]. Moskva: MIA, 2015. 920 p (in Russ.).

4. Bitsadze V.O., Makatsariya A.D., Khizroeva D.Kh. et al. Thrombophilia as the most important link in the pathogenesis of pregnancy complications. [Trombofiliya kak vazhnejshee zveno patogeneza oslozhnenij beremennosti]. Prakticheskaya medicina. 2012;(5):22–9 (in Russ.).

5. Kovac M., Mitic G., Micovic Z. et al. Thrombophilia in women with pregnancy-associated complications: fetal loss and pregnancy-related venous thromboembolism. Gynecol Obstet Invest. 2010;69(4):233–8.

6. Akinshina S.V., Bitsadze V.O., Makatsariya A.D. et al. Thrombophilia and thromboembolic complications associated with assisted reproductive technologies. [Trombofiliya i tromboembolicheskie oslozhneniya, svyazannye s ispol'zovaniem vspomogatel'nyh reproduktivnyh tekhnologij]. Akusherstvo, ginekologiya i reprodukciya. 2014;8(2):89–96 (in Russ.).

7. Di Nisio М., Rutjes A.W., Ferrante N. et al. Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis. Blood. 2011;118(10):2670–8.

8. Mazhar S.B., Emanuel A. Haematological defects in recurrent pregnancy loss. Haematology Updates. 2011. 56–60.

9. Nelson S.M., Greer I.A. The potential role of heparin in assisted conception. Hum Reprod. Update. 2008;14(6):623–45.

10. Makatsaria A.D., Akinshina S.V., Bitsadze V.O., Andreeva MD. Clinical picture, diagnosis and prevention of venous thromboembolic complications during pregnancy. [Klinika, diagnostika i profilaktika venoznyh tromboembolicheskih oslozhnenij vo vremya beremennosti]. Akusherstvo, ginekologiya i reprodukciya. 2014;8(4):27–35 (in Russ.).

11. Arnout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost. 1996;75(4):536–41.

12. Stuleva N.S., Khizroeva D.Kh., Mashkova T.Ya., Abramyan G.R. Circulation of antiphospholipid antibodies and IVF failure. [Cirkulyaciya antifosfolipidnyh antitel i neudachi EKO]. Akusherstvo, ginekologiya i reprodukciya. 2015;9(3):6–10 (in Russ.).

13. Selkhadzhieva M.S., Abramyan G.R., Stuleva N.S. Spectrum of antiphospholipid antibodies in patients with fetal loss syndrome. [Spektr antifosfolipidnyh antitel u pacientok s sindromom poteri ploda]. Akusherstvo, ginekologiya i reprodukciya. 2014;8(4):84 (in Russ.).

14. Makatsaria N.A., Khizroeva D.Kh., Bitsadze V.O. et al. Antiphospholipid antibodies in patients with IVF. [Antifosfolipidnye antitela u pacientok s EKO]. Akusherstvo, ginekologiya i reprodukciya. 2014;8(4):93 (in Russ.).

15. Tong M., Viall C.A., Chamley L.W. Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment. Hum Reprod Update. 2015;21(1):97–118.

16. Hoayek J.G., Moussa H.N., Rehman H.A. et al. Catastrophic antiphospholipid syndrome in pregnancy, a diagnosis that should not be missed. J Matern Fetal Neonatal Med. 2016;29(24):3950–5.

17. Ruffatti A., Salvan E., Del Ross T. et al. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. Thromb Haemost. 2014;112(4):727–35.

18. Makatsariya A.D., Akinshina S.V., Bitsadze V.O., Khizroeva D.Kh., Stuleva N.S. Acquired form of ADAMTS-13 deficiency as a cause of thrombotic microangiopathy in a pregnant woman with repeated disturbances of cerebral circulation, venous thromboembolism, preeclampsia, and fetal loss syndrome. [Priobretennaya forma nedostatochnosti ADAMTS-13 kak prichina tromboticheskoj mikroangiopatii u beremennoj s povtornymi narusheniyami mozgovogo krovoobrashcheniya, venoznym tromboembolizmom, preeklampsiej i sindromom poteri ploda]. Akusherstvo i ginekologiya. 2017;(5):138–42 (in Russ.).

19. Khizroeva D.Kh., Mikhaylidi I.A., Stuleva N.S. The value of protein C determination in obstetric practice. [Znachenie opredeleniya proteina S v akusherskoj praktike]. Prakticheskaya medicina. 2014;7(76):52–7 (in Russ.).

20. Zimmerman M.A., Cameron A.M., Ghobrial R.M. Budd-Chiari syndrome. Clin Liver Dis. 2006;10(2):259–73.

21. Makatsariya A.D., Akinshina S.V. Thrombosis of rare localization and thrombophilia. [Trombozy redkoj lokalizacii i trombofiliya]. Akusherstvo, ginekologiya i reprodukciya. 2014;8(2):97–111 (in Russ.).

22. De Laat B., Wu X.X., van Lummel M. et al. Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood. 2007;109(4):1490–4.

23. Quinn A.S., Wu X.X., Rand J.H., Taatjes D.J. Insights into the pathophysiology of the antiphospholipid syndrome provided by atomic force microscopy. Micron. 2012;43(8):851–62.

For citation:

Stuleva N.S., Vorobiev A.V., Orudzhova E.A. A case of mesenteric vein thrombosis developed in the first trimester of pregnancy after in vitro fertilization and embryo transfer in a patient with antiphospholipid syndrome. Obstetrics, Gynecology and Reproduction. 2018;12(4):72-78. (In Russ.)

Views: 439

ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)